| A three-dimensional (3D) organotypic microfluidic model for glioma stem cells–Vascular interactions D Truong, R Fiorelli, ES Barrientos, EL Melendez, N Sanai, S Mehta, ... Biomaterials 198, 63-77, 2019 | 136 | 2019 |
| Novel experimental model of brain arteriovenous malformations using conditional Alk1 gene deletion in transgenic mice C Han, MJ Lang, CL Nguyen, EL Melendez, S Mehta, GH Turner, ... Journal of neurosurgery 137 (1), 163-174, 2021 | 11 | 2021 |
| Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells CL Cascio, JB McNamara, EL Melendez, EM Lewis, ME Dufault, N Sanai, ... JCI insight 6 (17), 2021 | 11 | 2021 |
| Characterization of diverse homoserine lactone synthases in Escherichia coli R Daer, CM Barrett, EL Melendez, J Wu, SJ Tekel, J Xu, B Dennison, ... PloS one 13 (8), e0202294, 2018 | 11 | 2018 |
| Enhanced tissue penetration of antibodies through pressurized immunohistochemistry R Fiorelli, GS Sidhu, A Cebrián-Silla, EL Melendez, S Mehta, ... bioRxiv, 2020.09. 25.311936, 2020 | 7 | 2020 |
| DDRE-23. PRECLINICAL EVALUATION OF BRAIN PENETRATION PROPERTIES OF NEW FIRST-IN-CLASS LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) INHIBITOR, SP-2577 J Jiang, B Hopkins, G Hook, EL Melendez, A Tovmasyan, S Mehta, J Li, ... Neuro-Oncology 23 (Suppl 6), vi79, 2021 | 2 | 2021 |
| Quisinostat is a brain-penetrant radiosensitizer in glioblastoma CL Cascio, T Margaryan, E Luna-Melendez, JB McNamara, CI White, ... JCI insight 8 (22), 2023 | 1 | 2023 |
| 505MO A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients N Sanai, S Desai, T Margaryan, CL Cascio, M Elliott, J Molloy, J Harmon, ... Annals of Oncology 34, S394, 2023 | 1 | 2023 |
| 5-aminolevulinic acid, fluorescein sodium, and indocyanine green for glioma margin detection: analysis of operating wide-field and confocal microscopy in glioma models of … E Belykh, L Bardonova, I Abramov, VA Byvaltsev, T Kerymbayev, K Yu, ... Frontiers in oncology 13, 1156812, 2023 | 1 | 2023 |
| EXTH-09. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR … S Mehta, A Tovmasyan, AC Tien, M Holter, B Hopkins, T Margaryan, ... Neuro-Oncology 23 (Supplement_6), vi165-vi165, 2021 | 1 | 2021 |
| STEM-25. HDAC1 IS ESSENTIAL FOR GLIOMA STEM CELL SURVIVAL CL Cascio, J McNamara, EL Melendez, S Mehta Neuro-Oncology 21 (Suppl 6), vi239, 2019 | 1 | 2019 |
| Abstract CT044: A phase 0/1b study of AZD1390 plus radiotherapy in newly-diagnosed, MGMT-unmethylated glioblastoma patients N Sanai, S Desai, T Margaryan, J Molloy, C LoCascio, M Elliott, J Harmon, ... Cancer Research 84 (7_Supplement), CT044-CT044, 2024 | | 2024 |
| Acute and long-term responses to treatment with the HDAC inhibitor quisinostat in preclinical models of glioblastoma K Orndorff, J McNamara, M Stavnichuk, CL Cascio, C White, EL Melendez, ... Cancer Research 84 (6_Supplement), 3222-3222, 2024 | | 2024 |
| Tumor pharmacokinetics and pharmacodynamics assessment of TEAD inhibitor VT03989 in patient-derived xenograft models of glioblastoma T Margaryan, YW Chang, J Molloy, B Hopkins, M Elliott, EL Melendez, ... Cancer Research 84 (6_Supplement), 1660-1660, 2024 | | 2024 |
| TUMOR PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE PRMT5 INHIBITOR SKL27969 AC Tien, T Margaryan, J Molloy, J McNamara, W Knight, R Hon, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| EXTH-30. PHARMACOKINETICS-AND PHARMACODYNAMICS-BASED EVALUATION OF QUISINOSTAT AS A RADIOSENSITIZER IN PRECLINICAL MODELS OF GBM CL Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, C White, ... Neuro-Oncology 24 (Supplement_7), vii216-vii216, 2022 | | 2022 |
| Pharmacokinetics-and pharmacodynamics-based evaluation of quisinostat as a radiosensitizer in preclinical models of human glioblastoma CL Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, S Himes, ... Cancer Research 82 (12_Supplement), 349-349, 2022 | | 2022 |
| EXTH-24. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE SECOND-GENERATION HDAC … C Lo Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, ... Neuro-Oncology 23 (Supplement_6), vi168-vi168, 2021 | | 2021 |
| NON-REDUNDANT, ISOFORM-SPECIFIC ROLES OF HDAC1 IN THE REGULATION OF THE GLIOMA STEM CELL PHENOTYPE C Lo Cascio, J McNamara, EL Melendez, E Lewis, M Dufault, N Sanai, ... NEURO-ONCOLOGY 23, 25-25, 2021 | | 2021 |
| NIMG-27. EVALUATING THE POTENTIAL OF 18F-FLUCICLOVINE POSITRON EMISSION TOMOGRAPHY TO DETECT WHOLE BRAIN TUMOR BURDEN: A PRECLINICAL STUDY M Scarpelli, D Healey, EL Melendez, S Mehta, C Quarles Neuro-oncology, 2019 | | 2019 |
